
Previously categorized as a health issue affecting women, bacterial vaginosis (BV) is frequently treated in isolation, excluding male sexual partners. However, recent data suggests that the reason BV recurs at alarmingly high rates may be due to the failure to treat both partners.
When there is an imbalance in the vaginal microbiome—a decrease in beneficial bacteria and an increase in pathogenic bacteria—bacterial vaginosis results. Although many women have no symptoms at all, this disturbance might cause an unpleasant fishy odor, odd vaginal discharge, itching, or a burning feeling. Although BV is sometimes dismissed as a straightforward imbalance and not a severe health issue, it is linked to significant hazards including an increased risk of STIs, pelvic inflammatory disease, and pregnancy-related issues like low birth weight and early delivery.
Because the bacteria that cause BV originate inside the body rather than from external infections, it has not always been classified as an STI. However, mounting data suggests that this understanding was incomplete and that sexual transmission may play a significant role in BV recurrence.
Numerous studies have shown that recurrence rates of BV are significant; almost half of women experience a relapse within the first six months after starting antibiotic therapy. One of the main causes of these recurrences is reinfection by untreated male partners. The idea that males can re-infect their female partners with BV-associated bacteria is supported by studies that have discovered these germs in the male urethra and penile skin.